These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biomarkers: Their potential in the diagnosis and treatment of heart failure. Heil B; Tang WH Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S28-35. PubMed ID: 26694889 [TBL] [Abstract][Full Text] [Related]
4. Novel heart failure biomarkers: why do we fail to exploit their potential? Piek A; Du W; de Boer RA; Silljé HHW Crit Rev Clin Lab Sci; 2018 Jun; 55(4):246-263. PubMed ID: 29663841 [TBL] [Abstract][Full Text] [Related]
5. Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects. Vassalle C; Masotti S; Lubrano V; Basta G; Prontera C; Di Cecco P; Del Turco S; Sabatino L; Pingitore A Eur J Appl Physiol; 2018 Feb; 118(2):411-417. PubMed ID: 29256048 [TBL] [Abstract][Full Text] [Related]
6. Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy. Sharim J; Daniels LB Curr Cardiol Rep; 2020 May; 22(6):41. PubMed ID: 32430626 [TBL] [Abstract][Full Text] [Related]
7. Novel biomarkers in heart failure with preserved ejection fraction. Shah KS; Maisel AS Heart Fail Clin; 2014 Jul; 10(3):471-9. PubMed ID: 24975910 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure. Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907 [TBL] [Abstract][Full Text] [Related]
9. State of the Art: Newer biomarkers in heart failure. de Boer RA; Daniels LB; Maisel AS; Januzzi JL Eur J Heart Fail; 2015 Jun; 17(6):559-69. PubMed ID: 25880523 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers in heart failure: the past, current and future. Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637 [TBL] [Abstract][Full Text] [Related]
11. Novel biomarkers predicting cardiac function after acute myocardial infarction. Feistritzer HJ; Klug G; Reinstadler SJ; Reindl M; Mayr A; Mair J; Metzler B Br Med Bull; 2016 Sep; 119(1):63-74. PubMed ID: 27418651 [TBL] [Abstract][Full Text] [Related]
12. The search for efficient diagnostic and prognostic biomarkers of heart failure. Emdin M; Mirizzi G; Pastormerlo LE; Poletti R; Giannelli E; Prontera C; Passino C; Vergaro G Future Cardiol; 2016 May; 12(3):327-37. PubMed ID: 27092725 [TBL] [Abstract][Full Text] [Related]
13. The use of biomarkers in the patient with heart failure. Chowdhury P; Kehl D; Choudhary R; Maisel A Curr Cardiol Rep; 2013 Jun; 15(6):372. PubMed ID: 23644993 [TBL] [Abstract][Full Text] [Related]
14. Sex-Related Aspects of Biomarkers in Cardiac Disease. Mingels AMA; Kimenai DM Adv Exp Med Biol; 2018; 1065():545-564. PubMed ID: 30051406 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers in cardiovascular medicine: towards precision medicine. Gualandro DM; Twerenbold R; Boeddinghaus J; Nestelberger T; Puelacher C; Müller C Swiss Med Wkly; 2019 Oct; 149():w20125. PubMed ID: 31656035 [TBL] [Abstract][Full Text] [Related]
16. Galectin-3, a prognostic marker--and a therapeutic target? Pereira AR; Menezes Falcão L Rev Port Cardiol; 2015 Mar; 34(3):201-8. PubMed ID: 25746675 [TBL] [Abstract][Full Text] [Related]
17. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy. Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913 [TBL] [Abstract][Full Text] [Related]